Afectación del sistema nervioso por la COVID-19
Resumen
Palabras clave
Referencias
Savón CE, Acosta B, Piñón A, Valdés O, Oropesa S I, González G. Infección respiratoria aguda grave en pacientes cubanos durante la ola de influenza pandémica A (H1N1) en Cuba. Rev Cubana Medicina Trop. 2011;63(1), 30-7. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602011000100005
Cuba Ministerio de Salud P. Plan para el enfrentamiento de la pandemia Influenza A (H1N1). 2009. Disponible en: http://files.sld.cu/pdvedado/files/2009/09/final_plan_para_el_enfrentamiento_de_pandemia.pdf
Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Journal 2020. doi: https://doi.org/10.1101/2020.02.22.20026500
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995-998. doi: 10.1021/acschemneuro.0c00122.
Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke & Vascular Neurology 2020;0. doi:10.1136/svn-2020-000382.
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;1-4. doi: 10.1002/jmv.25728.
To KF, Lo AW. Exploring the pathogenesis of severe acute respiratorysyndrome (SARS): the tissue distribution of the coronavirus (SARSCoV)and its putative receptor, angiotensin-converting enzyme 2(ACE2). J Pathol. 2004;203:740-3. doi: 10.1002/path.1597
Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80(4):394-400. doi: 10.1016/j.jinf.2020.02.017.
Zhao K., Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv preprint. 2020. doi: https://doi.org/10.1101/2020.03.16.20035105 .
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology. 2020: 201187. doi: 10.1148/radiol.2020201187.
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; pii: S1474-4422(20)30109-5. doi: 10.1016/S1474-4422(20)30109-5.
Steardo L, Steardo LJr, Zorec R, Verkhratsky A. Neuroinfeccion may potentially contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiologica. 2020. doi:https://doi.org/10.1111/apha.13473
Talan J. COVID-19: Neurologists in Italy to Colleagues in US: Look for Poorly Defined Neurologic Conditions in Patients with the Coronavirus. Neurology Today.2020. Disponible en: https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=920

Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.